Carter L. Diggs

United States Agency for International Development — United States

Medicine · Health Sciences

38h-index6.1kcitations102works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Malaria Research and Control(59), Mosquito-borne diseases and control(40), vaccines and immunoinformatics approaches(17), Trypanosoma species research and implications(16), Research on Leishmaniasis Studies(14)

Publications102 total

RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting
Frontiers in Cellular and Infection Microbiology·2022· 20 citedOpen Access
Immunization
2022
A three-antigen Plasmodium falciparum DNA prime—Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults
PLoS ONE·2021· 21 citedOpen Access
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
Med·2021· 156 citedOpen Access
Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02A
Malaria Journal·2019· 11 citedOpen Access
MOESM2 of Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02A
Figshare·2019Open Access
MOESM3 of Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02A
Figshare·2019Open Access
MOESM1 of Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02A
Figshare·2019Open Access
A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection
npj Vaccines·2017· 67 citedOpen Access
Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine
PLoS ONE·2017· 15 citedOpen Access
Correction: Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes
PLoS ONE·2016· 3 citedOpen Access
Vaccine Strain-Specificity of Protective HLA-Restricted Class 1 P. falciparum Epitopes
PLoS ONE·2016· 16 citedOpen Access
Strain-specific Plasmodium falciparum multifunctional CD4+ T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate
Vaccine·2016· 11 cited
Demonstration of the Blood-Stage<i>Plasmodium falciparum</i>Controlled Human Malaria Infection Model to Assess Efficacy of the<i>P. falciparum</i>Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01
The Journal of Infectious Diseases·2016· 113 citedOpen Access
Immunological Research on African Trypanosomiasis
Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy·2015· 11 cited
Sterile Immunity to Malaria after DNA Prime/Adenovirus Boost Immunization Is Associated with Effector Memory CD8+T Cells Targeting AMA1 Class I Epitopes
PLoS ONE·2014· 62 citedOpen Access
Extended Safety, Immunogenicity and Efficacy of a Blood-Stage Malaria Vaccine in Malian Children: 24-Month Follow-Up of a Randomized, Double-Blinded Phase 2 Trial
PLoS ONE·2013· 42 citedOpen Access
Human adenovirus 5-vectored<i>Plasmodium falciparum</i>NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection
Human Vaccines & Immunotherapeutics·2013· 37 citedOpen Access
Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)
Malaria Journal·2013· 42 citedOpen Access
DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity
PLoS ONE·2013· 139 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Lorraine Soisson(23), D. Gray Heppner(14), Sheetij Dutta(13), Evelina Angov(11), Michael R. Hollingdale(10), Christian F. Ockenhouse(10), Joe Cohen(10), W. Ripley Ballou(9), Marie‐Claude Dubois(8), David E. Lanar(8), Thomas L. Richie(8), J. David Haynes(7), V. Ann Stewart(7), Kent E. Kester(7), Meng Shi(7), Martha Sedegah(7), Cindy Tamminga(7), Harini Ganeshan(7), María Belmonte(7), Wayne T. Hockmeyer(6)